Zacks: Brokerages Anticipate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Will Announce Earnings of $0.56 Per Share

Wall Street brokerages expect DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) to post earnings of $0.56 per share for the current fiscal quarter, Zacks reports. Eight analysts have issued estimates for DENTSPLY SIRONA’s earnings. The highest EPS estimate is $0.65 and the lowest is $0.49. DENTSPLY SIRONA reported earnings per share of $0.71 during the same quarter last year, which would indicate a negative year over year growth rate of 21.1%. The firm is scheduled to report its next earnings report on Monday, January 1st.

On average, analysts expect that DENTSPLY SIRONA will report full-year earnings of $2.44 per share for the current fiscal year, with EPS estimates ranging from $2.37 to $2.62. For the next financial year, analysts forecast that the business will report earnings of $2.67 per share, with EPS estimates ranging from $2.55 to $2.78. Zacks’ EPS calculations are an average based on a survey of analysts that cover DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. DENTSPLY SIRONA’s revenue was up 841.1% compared to the same quarter last year. During the same period last year, the firm posted $0.72 earnings per share.

Several research firms recently weighed in on XRAY. Piper Sandler reaffirmed a “neutral” rating and issued a $46.00 price objective (down from $71.00) on shares of DENTSPLY SIRONA in a research note on Wednesday, April 20th. HC Wainwright reduced their price objective on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating on the stock in a research note on Friday, April 22nd. The Goldman Sachs Group reduced their price objective on DENTSPLY SIRONA from $59.00 to $47.00 and set a “neutral” rating on the stock in a research note on Thursday, April 21st. Morgan Stanley dropped their target price on DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating for the company in a research report on Wednesday, April 20th. Finally, Robert W. Baird downgraded DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and dropped their target price for the company from $67.00 to $48.00 in a research report on Tuesday, April 19th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $52.89.

In other news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total transaction of $273,999.00. Following the completion of the transaction, the director now directly owns 35,155 shares in the company, valued at $1,396,005.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.76% of the stock is owned by company insiders.

A number of institutional investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company grew its stake in DENTSPLY SIRONA by 61.4% in the first quarter. The Manufacturers Life Insurance Company now owns 268,365 shares of the medical instruments supplier’s stock valued at $13,209,000 after acquiring an additional 102,134 shares during the period. Toroso Investments LLC grew its stake in DENTSPLY SIRONA by 12.9% in the first quarter. Toroso Investments LLC now owns 9,175 shares of the medical instruments supplier’s stock valued at $452,000 after acquiring an additional 1,050 shares during the period. Worldquant Millennium Advisors LLC purchased a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $12,912,000. KB Financial Partners LLC boosted its position in shares of DENTSPLY SIRONA by 19.5% during the first quarter. KB Financial Partners LLC now owns 4,443 shares of the medical instruments supplier’s stock valued at $219,000 after buying an additional 726 shares during the last quarter. Finally, SkyView Investment Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 17.0% during the first quarter. SkyView Investment Advisors LLC now owns 4,878 shares of the medical instruments supplier’s stock valued at $240,000 after buying an additional 710 shares during the last quarter. 94.79% of the stock is owned by hedge funds and other institutional investors.

NASDAQ:XRAY traded up $0.77 during trading hours on Friday, hitting $39.72. The company’s stock had a trading volume of 1,759,175 shares, compared to its average volume of 2,277,233. The stock has a fifty day simple moving average of $43.54 and a 200-day simple moving average of $49.92. The company has a market capitalization of $8.56 billion, a P/E ratio of 23.50 and a beta of 0.94. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 1.03. DENTSPLY SIRONA has a twelve month low of $35.00 and a twelve month high of $67.69.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 8th. Stockholders of record on Friday, June 24th will be given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.26%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 29.59%.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Further Reading

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.